Clinical Trial Update: A Trial of Nadolol Plus Isosorbide Mononitrate Versus Carvedilol for the Prevention of Variceal Rebleeding [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing nadolol plus isosorbide mononitrate versus carvedilol for preventing variceal rebleeding has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Variceal Bleeding
• Liver Cirrhosis
• Portal Hypertension

Drugs mentioned

• CARVEDILOL (Carvedilol)
• Isosorbide Mononitrate (isosorbide mononitrate)
• Nadolol (Nadolol)

Snippet

Sponsor: E-DA Hospital | Conditions: Variceal Rebleeding | Phase 4 | Status: COMPLETED